Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl‐2/Cyt‐c/caspase‐dependent pathways in the oxygen–glucose deprived SHSY‐5Y cell lines: In silico and in vitro study
Ravi Kumar Rajan,M. Ramanathan
DOI: https://doi.org/10.1111/cbdd.14458
2024-02-22
Chemical Biology & Drug Design
Abstract:JNK3 serves as a neuronal kinase with the capacity for activation upon exposure to stress response like oxygen–glucose deprivation. Upon phosphorylation and activation, JNK3 relocates to the mitochondria, where it is thought to enhance the permeability of the mitochondrial outer membrane (MOMP). This heightened MOMP leads to the release of Cyt‐c into the cytoplasm, forming a complex with apaf‐1 that triggers enzyme activation. This intricate assembly gives rise to apoptosome, responsible for initiating the activation sequence of caspase‐9 and caspase‐3, pivotal players in neuronal damage. Our investigation suggests that PCT and SP6 compete for the ATP‐binding site of JNK3, consequently impeding its translocation into the mitochondria amid stress‐induced conditions. PCT displayed neuroprotection, as evinced by its discernible reduction of factors linked to apoptosis, encompassing caspases 3 and 9, alongside the attenuation of cyt‐c mRNA expression. Furthermore, PCT exerted a regulatory effect on the expression levels of Bcl‐2 and JNK3, exerting influence over cellular survival pathways. Most notably, PCT exhibited a promising propensity for fostering neurogenesis, as underscored by the elevation in mRNA expression of NgN1, neuroD2, and survivin, highlighting PCT's intrinsic neuroprotective activity. JNK3, a neuronal kinase activated by stress, plays a role in stress‐induced apoptosis, leading to neuronal cell death following cerebral ischemia. This study investigates the neuroprotective effects of piceatannol (PCT) in SHSY‐5Y neuroblastoma cells after hypoxic injury and its interaction with JNK3. We analyzed the crystal coordinates, interaction energies, and amino acid interactions to determine PCT's selectivity for JNK3. The electrostatic potential was computed using density functional theory, while molecular dynamics assessed the stability and structural consistency of the JNK3‐PCT complex. We used SP600125 (SP6), a JNK3 inhibitor, as a reference compound. Additionally, we performed cell‐free JNK 1, 2, and 3 kinase assays to evaluate the isoform selectivity of PCT. Cytotoxicity and cell viability were determined by an MTT test. To assess apoptosis, we used acridine orange/ethidium bromide dual fluorescent labeling and ANNEXIN A5‐FITC flow cytometry. Western blot was used to evaluate the attenuation of JNK3 and apoptotic proteins. In silico studies revealed a stronger binding affinity between PCT and JNK3 compared to JNK1 and JNK2, which was further supported by the in vitro kinase assay. PCT‐treated cells exhibited a decrease in Cyt‐c and caspase‐3 expression and an increase in Bcl‐2 level, compared to hypoxic control (p
biochemistry & molecular biology,chemistry, medicinal